https://twitter.com/NephRodby/status/1730441765843309008@ssfarouk @ASNKidney @suresh_varsh94 @AbhinayaS15 @MadhusudanV92 @Doug_Rud @ISMMSKidney But did you get the question I submitted to the #KidneyWk FIT Bowl correct? The answer was 5-oxoproline or pyroglutamic acid.
— Roger Rodby (@NephRodby) Dec 1, 2023
Thursday, November 30, 2023
@NephRodby
http://twitter.com/NephRodby
@ssfarouk
http://twitter.com/ssfarouk
https://twitter.com/ssfarouk/status/1730401604556181659.@ASNKidney 2023 FIT Bowl Champions with their 🏆🥇🥇🥇 Congratulations @suresh_varsh94 @AbhinayaS15 @MadhusudanV92 @Doug_Rud @ISMMSKidney #Nephrology #KidneyWk https://bit.ly/3uMPyDZ
— Samira Farouk, MD, MSCR (@ssfarouk) Dec 1, 2023
@Acute_Baxter_US
http://twitter.com/Acute_Baxter_US
https://twitter.com/Acute_Baxter_US/status/1730286829050458398Couldn’t make it to #KidneyWk ? No worries! We’d love to talk to you about the difference our TOTAL KIDNEY CARE SUPPORT could make to your practice! Let’s connect! 👉 https://bit.ly/3N6kB4f https://bit.ly/3SYe3bA
— Acute Therapies at Baxter - U.S. (@Acute_Baxter_US) Nov 30, 2023
@Nephronline
http://twitter.com/Nephronline
https://twitter.com/Nephronline/status/1730270732309983243🇦🇺 #Australia had the highest percentage of patients who chose home #dialysis, according to research from #KidneyWk. https://bit.ly/3Rn7Qoi
— Nephrology News & Issues (@Nephronline) Nov 30, 2023
@hswapnil
http://twitter.com/hswapnil
https://twitter.com/hswapnil/status/1730232650399416691@poyanmehr @GrahamAbra @kidney_boy @HumphreysLab <my version of Tom Friedman talking to a cab driver> Speaking to a few US based fellows/younger nephrons at #KidneyWk - money seems to be the big factor (rheum/endo notwithstanding - perhaps its money + lifestyle: lifestyle hasn't changed in neph over the years, but money has)
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Nov 30, 2023
@ardelyx
http://twitter.com/ardelyx
https://twitter.com/ardelyx/status/1730210228132602191#TBT to an incredible #ASN #KidneyWk. Thanks to everyone who stopped by our booth, checked out our posters, attended our Exhibitor Spotlight and connected with our team. See you next year! #ArdelyxProud https://bit.ly/3N2ZJL9
— Ardelyx (@ardelyx) Nov 30, 2023
Wednesday, November 29, 2023
@NephJC
http://twitter.com/NephJC
https://twitter.com/NephJC/status/1729899016832577849Here is the live recorded @freelyfiltered episode, where the crew discussed about DUPLEX trial @rheault_m after opening #KidneyWK LBCT, didn’t considered herself too cool to come, pop up on the scen, then party with #NephJC people https://bit.ly/47yukIM
— Nephrology Journal Club (@NephJC) Nov 29, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1729893163542941705#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/3RnLYcB https://bit.ly/3uCXVCe https://bit.ly/47Srr5h
— GlomCon (@GlomCon) Nov 29, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1729892863822229701#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/3RnLYcB https://bit.ly/47Srr5h
— GlomCon (@GlomCon) Nov 29, 2023
Tuesday, November 28, 2023
@NephJC
http://twitter.com/NephJC
https://twitter.com/NephJC/status/1729695173485985849Here is the live recorded @freelyfiltered episode, where the crew discussed about DUPLEX trial @rheault_m after opening #KidneyWK LBCT, didn’t consider herself too cool to come, pop up on the scene, then party with #NephJC people https://bit.ly/3SXbUgh
— Nephrology Journal Club (@NephJC) Nov 29, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1729634670453637624#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/46A4mDe https://bit.ly/3uC0YKP
— GlomCon (@GlomCon) Nov 28, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1729632548681105545#KidneyWk GN pearl of the day: Corticosteroid Dose and Risk of Infection in Children and Adults with Glomerular Disease: An Analysis of the @CureGn Study Highlighting the importance of steroid-sparing regimens (?also infection prophylaxis?) https://bit.ly/3R7U5J0 https://bit.ly/3RlQ3xY https://bit.ly/3QYG8Ne
— GlomCon (@GlomCon) Nov 28, 2023
@VelezNephHepato
http://twitter.com/VelezNephHepato
https://twitter.com/VelezNephHepato/status/1729521361683366322If you miss this session during #KidneyWk because you were at the high-impact clinical trials, this is your chance now https://bit.ly/46FyrBf https://bit.ly/3SXsFrL
— Juan Carlos Q Velez (@VelezNephHepato) Nov 28, 2023
Monday, November 27, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1729369762113937743#KidneyWk pearl today: A @CureGn study on medication adherence. Perhaps one of the primary reasons for "treatment failure" or "treatment-refractory disease." Important insights into barriers to medication adherence reported by @JKrissberg et al. https://bit.ly/3MYv7KQ https://bit.ly/3GoEP5a https://bit.ly/3RjFA67
— GlomCon (@GlomCon) Nov 28, 2023
@tessa_novick
http://twitter.com/tessa_novick
https://twitter.com/tessa_novick/status/17292479123734815015/ Among 32 dialysis patients with low SES, 44% reported unstable housing and 63% reported food insecurity. Dialysis led to and exacerbated social needs, and social needs fragmented care & increased stress. Findings reported at #KidneyWk 2023 @DrLizJacobs @DrDeidraCrews https://bit.ly/47ulr2P
— Tessa Novick, MD, MSW, MHS (@tessa_novick) Nov 27, 2023
@ASNKidney
http://twitter.com/ASNKidney
https://twitter.com/ASNKidney/status/1729228765094355425📣 ASN Kidney Week On-Demand Now Available 📣 Access insights, lectures, and discussions from ASN #KidneyWk 2023 anytime, anywhere. Use your onsite access code or purchase the online product today! Get started: https://bit.ly/3QZ0plP https://bit.ly/40UKE3X
— American Society of Nephrology (@ASNKidney) Nov 27, 2023
@DCHFT_Research
http://twitter.com/DCHFT_Research
https://twitter.com/DCHFT_Research/status/1729187354697687279Always great to see results being presented - the renal team are so pleased to have contributed to the #smileK study here @DCHFT. Thanks so much to all our patients that took part! #TeamDCH #BePartofResearch @mykidneysandme #ResearchActiveTrust #KidneyWk #kidneyresearch https://bit.ly/3sUGVa8
— DCHFT Research (@DCHFT_Research) Nov 27, 2023
@somaticediting
http://twitter.com/somaticediting
https://twitter.com/somaticediting/status/1729179385805390067ICYMI: #SCGE investigator @benofreedman accepted the @ASNKidney/@AHAScience 2023 Young Investigator Award at #KidneyWK 2023 👏👏 Listen to his address here ⬇️ https://bit.ly/49Tybl0
— Somatic Cell Genome Editing (SCGE) Outreach (@somaticediting) Nov 27, 2023
Sunday, November 26, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1728936893738614793#KidneyWk pearls continued 👇 Lots of discussion around SGLT2i in IGAN. @AyoubIsabelle and @BradRovin provided a sneak preview of the PROTECT Open-Label Extension and SPARTACUS studies Spoiler alert 🚨 well tolerated + additional proteinuria reduction. More to come… https://bit.ly/46Aj9Ol https://bit.ly/40UBFzQ https://bit.ly/40UBGDU
— GlomCon (@GlomCon) Nov 27, 2023
@Stones__
http://twitter.com/Stones__
https://twitter.com/Stones__/status/1728771255304945746Thanks @GlomCon Credit to @Sorcha0792 @kiplet69 @THKC1 @Allysonegan1 #KidneyWk https://bit.ly/49QRJGO https://bit.ly/3GkijKZ
— Sinead Stoneman (@Stones__) Nov 26, 2023
Saturday, November 25, 2023
@edgarvlermamd
http://twitter.com/edgarvlermamd
https://twitter.com/edgarvlermamd/status/1728597461432705510Management of hyponatremia in the patient with heart failure: Use of urine sodium (and urine potassium) to assess diuretic response from @FH_Verbrugge #Nephpearls #Cardiorenal #KidneyWk 👉 https://bit.ly/3Gh0HQ3 https://bit.ly/3GeK9rW
— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) Nov 26, 2023
@edgarvlermamd
http://twitter.com/edgarvlermamd
https://twitter.com/edgarvlermamd/status/1728593015147495560Using DDAVP in correction of hyponatremia from @NephroMD #Nephpearls #KidneyWk 📌 Proactive strategy 📌 Reactive strategy 📌 Rescue strategy 👉 https://bit.ly/40TsHCG 👉 https://bit.ly/3T3IeOJ https://bit.ly/412oo8s
— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) Nov 26, 2023
@edgarvlermamd
http://twitter.com/edgarvlermamd
https://twitter.com/edgarvlermamd/status/1728588202687000967Treatment of Hyponatremia from @NephroMD #Nephpearls #KidneyWk 📌 Use of Hypertonic Saline (HTS) 📌 Management of severely symptomatic hyponatremia 📌 Pitfalls of correction 📌 Risk factors for rapid correction 👉 https://bit.ly/49TZdbX https://bit.ly/3MXPjfy
— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) Nov 26, 2023
@kidneyrebel
http://twitter.com/kidneyrebel
https://twitter.com/kidneyrebel/status/1728557966935167228Listening to @nishakidneydoc and @nephroshah on how #KidneyWk set them on the path to #Nephrology. Bring your uber talented mentees to Kidney Week 2024! Also like hearing about a shift to how on home dialysis and a focus on early treatments. https://bit.ly/49W6p7M
— Kidney Rebel (@kidneyrebel) Nov 25, 2023
Friday, November 24, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1728246388600037726#KidneyWk pearl An interesting report by @Stones__ and colleagues on ANCA-negative pauci-immune glomerulonephritis What explains the worse kidney function at the time of diagnosis - delay in diagnosis or more aggressive disease? https://bit.ly/3MXDXs9 https://bit.ly/47R48sD https://bit.ly/3SYZ3dC
— GlomCon (@GlomCon) Nov 25, 2023
@raad_chowdhury
http://twitter.com/raad_chowdhury
https://twitter.com/raad_chowdhury/status/1728227650089718193Listen to our ASN Podcast! Thank you @ASNKidney for inviting us to discuss science, healthcare equity, and the future of Nephrology! My voice on 4 hours of sleep with two different session to moderate but, we made it happen! #kidneywk @angieloboMD @docdeepakdc https://bit.ly/49VdPbl
— Raad Chowdhury, MD, FASN (@raad_chowdhury) Nov 25, 2023
@kidneyrebel
http://twitter.com/kidneyrebel
https://twitter.com/kidneyrebel/status/1728147843561517385Great to hear the #KidneyWk 2023 Podcast: Day 3 with @raad_chowdhury, @angieloboMD, and Deepak Chandramohan, MD discuss onconephrology, diversity and the Kidney STARS program among other things. Excited for the future! https://bit.ly/47pUldh
— Kidney Rebel (@kidneyrebel) Nov 24, 2023
Thursday, November 23, 2023
@CMClase
http://twitter.com/CMClase
https://twitter.com/CMClase/status/1727891389004812536Congratulations to authors of these articles selected to receive the 2023 AJKD Editors' Choice Award: https://bit.ly/3Rexc7C #KidneyWk Including: @PD_Perls #PD https://bit.ly/3QQxrVm
— Catherine Clase 😷🌈 (@CMClase) Nov 24, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1727828339321368618#KidneyWk self-promotion 🤫 A GlomCon Real-World Evidence Study The Natural History of Focal and Segmental Glomerulosclerosis (FSGS) A large-scale, multi-center, RWE study of patients in diverse healthcare settings with a tissue diagnosis of FSGS https://bit.ly/3R8QhrX https://bit.ly/47uCYbg https://bit.ly/3RdjIsU
— GlomCon (@GlomCon) Nov 23, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1727822600351703381#KidneyWk pearls continues: Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with Focal Segmental Glomerulosclerosis (FSGS): Results from the Phase 3 DUPLEX Trial Presented by no one less than @rheault_m Watch here https://bit.ly/49T8txh https://bit.ly/49JGEHD https://bit.ly/49MMgAT
— GlomCon (@GlomCon) Nov 23, 2023
@arvindcanchi
http://twitter.com/arvindcanchi
https://twitter.com/arvindcanchi/status/1727707966470824418@hswapnil @calvapo @jfnephlolz There are folks who've used it and written about it.. There was a poster at #KidneyWk https://bit.ly/46pIdHH
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 23, 2023
@r3pakistan
http://twitter.com/r3pakistan
https://twitter.com/r3pakistan/status/1727619807661727800Protecting your kidneys involves adopting healthy lifestyle habits that contribute to overall kidney function and well-being. #kidneyhealth #kidney #kidneywk #healthcare #Health #healthylifestyle #healthylife #Pakistan #Islamabad https://bit.ly/47MrD68
— R3 Stem Cell Pakistan (@r3pakistan) Nov 23, 2023
Wednesday, November 22, 2023
@kdjhaveri
http://twitter.com/kdjhaveri
https://twitter.com/kdjhaveri/status/1727497351617520102@gudnephron @PaulHannaMD @glom_busterMD @MCW_Nephrology @koyaljainMD Thanks!!, we had fun time doing it #kidneywk 2023 @ASNKidney
— Kenar Jhaveri (@kdjhaveri) Nov 23, 2023
@GlomCon
http://twitter.com/GlomCon
https://twitter.com/GlomCon/status/1727374586235551842#KidneyWk had tons of exciting advances in glomerular diseases. Because it is more than one can absorb in a limited time, we have gone through all GN-related talks, presentations, and abstracts and will share some highlights here over the next few weeks here 🧵👇
— GlomCon (@GlomCon) Nov 22, 2023
@leicskidney
http://twitter.com/leicskidney
https://twitter.com/leicskidney/status/1727338853806288938Part of the team had a chance to attend @ASNKidney #KidneyWk in Philadelphia and present some of our SMILE-K @mykidneysandme findings this month. Read more about #ASN23 on our website! @CourtneyJLight @RBillany @SocSciHealth @uniofleicester @LeicResearch https://bit.ly/3QQkDy3
— Leicester Kidney Lifestyle Team (@leicskidney) Nov 22, 2023
@nourynizar
http://twitter.com/nourynizar
https://twitter.com/nourynizar/status/1727280542348124459I just published Revolutionize Prostate Health with Prostan Plus: Unleashing the Power of Nature for Optimal… ✅https://bit.ly/3R8GK4i #prostate #ProstateCancer #Cancer #MensHealth #healthcare #KidneyWk #Men #Over
— dani dani (@nourynizar) Nov 22, 2023
Tuesday, November 21, 2023
@AJKDonline
http://twitter.com/AJKDonline
https://twitter.com/AJKDonline/status/1727099623964074215Congratulations to authors of these articles selected to receive the 2023 AJKD Editors' Choice Award: https://bit.ly/3QIumI7 #KidneyWk https://bit.ly/3sJik86
— AJKD (@AJKDonline) Nov 21, 2023
@ASNKidney
http://twitter.com/ASNKidney
https://twitter.com/ASNKidney/status/1727073201535045984Are you feeling nostalgic for #KidneyWk? Over 12,300 participants from more than 100 countries engaged in provocative discussions and reasserted their commitment to advancing kidney care. Don't forget to submit your suggestions for next year: https://bit.ly/49OWa4K https://bit.ly/3SMF9SU
— American Society of Nephrology (@ASNKidney) Nov 21, 2023
@cavanaugh_do
http://twitter.com/cavanaugh_do
https://twitter.com/cavanaugh_do/status/1727043265785176547Did you love #kidneywk 2023 so much you already have ideas for next year? Me too - so share your ideas for GN sessions. We’d love to seem em. https://bit.ly/3MW13zo
— Corey Cavanaugh DO (@cavanaugh_do) Nov 21, 2023
Monday, November 20, 2023
@arvindcanchi
http://twitter.com/arvindcanchi
https://twitter.com/arvindcanchi/status/1726799837797208490Posters at #KidneyWk Tirzepatide demonstrated an increase in CysC-eGFR and reductions in UACR compared with placebo, suggesting renoprotective effects. These results warrant a long-term, prospective kidney outcome trial for people with obesity or overweight. SURMOUNT-1 Trial 👉… https://bit.ly/3QNIoH1 https://bit.ly/3R7pJar
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 21, 2023
@arvindcanchi
http://twitter.com/arvindcanchi
https://twitter.com/arvindcanchi/status/1726792604535378370More posters at #KidneyWk "pooled individual-level data from 15 trials that included patients with eGFR<30 mL/min/1.73 m2 to examine the effect of ACEi/ARB use on the risk of the onset of KFRT, or secondarily, death using Cox models. Data from this pooled individual-level… https://bit.ly/47jsnj6 https://bit.ly/3szjGSV
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 21, 2023
@arvindcanchi
http://twitter.com/arvindcanchi
https://twitter.com/arvindcanchi/status/1726791316561096731More posters at #KidneyWk "In participants with CKD and normal eGFR eating high acid-producing diets at baseline, dietary acid reduction over 5 years with either F+V or NaHCO3 yielded small but discernible improvements in acid-base status that might mediate slower CKD… https://bit.ly/49JU06u https://bit.ly/49WjldM
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 21, 2023
@kidneyrebel
http://twitter.com/kidneyrebel
https://twitter.com/kidneyrebel/status/1726757670818894091Excited to listen to Dr. George Bakris and Dr. Duc Quach talking about increased emphasis at #KidneyWk on transplant, diversity, and under represented populations plus new innovations coming to the Nephrology toolkit! https://bit.ly/3MQAImh
— Kidney Rebel (@kidneyrebel) Nov 21, 2023
@kidneyrebel
http://twitter.com/kidneyrebel
https://twitter.com/kidneyrebel/status/1726757287459484089Excited to listen to Dr. George Bakris and Dr. Duc Quach talking about increased emphasis at #KidneyWk on transplant, diversity, and under represented populations plus new innovations coming to the Nephrology toolkit! https://bit.ly/3MQAImh
— Kidney Rebel (@kidneyrebel) Nov 21, 2023
@benofreedman
http://twitter.com/benofreedman
https://twitter.com/benofreedman/status/1726646857903079782My #KidneyWk young investigator address is online! It has 3 (nephron) segments: 1) Disease in a Dish 2) Regenerative Medicine 3) The Bigger Picture (how to support students and young investigators) Watch it here: https://bit.ly/47gGkhM Thank you again @ASNKidney @KidneyInCVD
— Beno Freedman (@benofreedman) Nov 20, 2023
Sunday, November 19, 2023
@kidneyrebel
http://twitter.com/kidneyrebel
https://twitter.com/kidneyrebel/status/1726302178158301425Catching up on my #KidneyWk podcasts. Great to hear @kidney_boy and @jenniejlin’s enthusiasm for advances in the field. Thrilled to hear patient advocate Precious McCowan had served on the education committee, spoke, and moderated at Kidney Weeks. https://bit.ly/3MPLn0w
— Kidney Rebel (@kidneyrebel) Nov 19, 2023
@NephRodby
http://twitter.com/NephRodby
https://twitter.com/NephRodby/status/1726291226675269831@threadreaderapp @kianboy @jmteakell @ASNKidney @amyaimei The Audience Question and Answer session of our (@amyaimei and me) "Calming the Waters" hypoNa session. Was quite the event. #KidneyWk https://bit.ly/46hNCAt
— Roger Rodby (@NephRodby) Nov 19, 2023
Saturday, November 18, 2023
@nephondemand
http://twitter.com/nephondemand
https://twitter.com/nephondemand/status/1725996108873109755@drjosflynn @StotterMD @JonBKlein @ASNKidney @ASPNeph @Ped_Neph @mastodon @bluesky @Threads @instagram @hswapnil @rheault_m @kidney_boy @pedsnephrology 1/ Thanks Joe. Nephrology Twitter/X use has been decreasing for years. E.g., the amount of original content authored at the @ASNKidney meetings has fallen since 2015. Only 5.9 OTs authored per original author this #kidneywk. That drop is due to more than the ownership change. https://bit.ly/3R70N38
— Tejas Desai, MD MBA (@nephondemand) Nov 18, 2023
@Teknofiliac
http://twitter.com/Teknofiliac
https://twitter.com/Teknofiliac/status/1725922893534814223@eric_weinhandl From #KidneyWk this year: (Eric, you probably have the full poster?) My gut feeling was that the increase in catheter rates was a pandemic effect. Check the figure below. Do you see when things started to get worse? https://bit.ly/3R5ry7U
— Wael Hussein (@Teknofiliac) Nov 18, 2023
Friday, November 17, 2023
@Nephron826
http://twitter.com/Nephron826
https://twitter.com/Nephron826/status/1725673450109632738Thank you @msocoMD for this wonderful gift from #KidneyWk 2023 @ASNKidney . Goes perfectly well with my shorts (how else can you show the logo?) 😉 https://bit.ly/40QHfDm
— Rey Jaime Tan (@Nephron826) Nov 18, 2023
@WakeForestIM
http://twitter.com/WakeForestIM
https://twitter.com/WakeForestIM/status/1725665873569140802Our section on nephrology's third invited presentation at #KidneyWk @ASNKidney featured Dr. Anthony Bleyer kicking off the workshop 'Integrating genetic testing into general nephrology care' to a packed audience! https://bit.ly/3R1vcQ6
— Wake Forest Department of Internal Medicine (@WakeForestIM) Nov 18, 2023
@WakeForestIM
http://twitter.com/WakeForestIM
https://twitter.com/WakeForestIM/status/1725628879849840900Nephrology section chief, Dr. Barry Freedman, gave two invited talks at @ASNKidney #KidneyWk - APOL1 in Deceased Donor Kidney Transplantation - Anti-sense Oligonucleotide Therapy in APOL1 Nephropathy https://bit.ly/3R3Sx3J
— Wake Forest Department of Internal Medicine (@WakeForestIM) Nov 17, 2023
@WakeForestIM
http://twitter.com/WakeForestIM
https://twitter.com/WakeForestIM/status/1725596164005982576Packed audience for our nephrologist @MarianaMurea 's presentation "Incremental Hemodialysis in Patients with Residual Kidney Function: Is it Possible?" at the Dosing Hemodialysis Clinical Practice Session at @ASNkidney #KidneyWk https://bit.ly/49J3u1M
— Wake Forest Department of Internal Medicine (@WakeForestIM) Nov 17, 2023
@goKDIGO
http://twitter.com/goKDIGO
https://twitter.com/goKDIGO/status/1725591077573230782KDIGO sat down with @BradRovin to get his insights on the changing landscape in managing and treating #glomerular diseases and to share highlights in #IgAN from ASN #KidneyWk 2023. Watch the video: https://bit.ly/3R57se8 "There is a lot of excitement about glomerular disease… https://bit.ly/3ulBgdo
— KDIGO (@goKDIGO) Nov 17, 2023
Thursday, November 16, 2023
@DrDeidraCrews
http://twitter.com/DrDeidraCrews
https://twitter.com/DrDeidraCrews/status/1725265188948247023@ASNKidney #KidneyWk 2023 was amazing, & we're already preparing for Kidney Week 2024! Thrilled Drs. Tamara Isakova @NU_Nephrology & Rasheed Gbadegesin (@GbadegesinLab @DukeKidney) will lead the Kidney Week Education Committee! Submit session ideas: https://bit.ly/47dIizF https://bit.ly/47frKY1
— Deidra Crews, MD, ScM, FASN, MACP (@DrDeidraCrews) Nov 16, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1725249636313477324Patients with both cancer and diabetes who take sodium glucose cotransporter 2 inhibitors (SGLT2i) rather than glucagon-like peptide 1 receptor agonists (GLP-1 RA) have higher rates of certain adverse events, investigators reported at #KidneyWk. https://bit.ly/3G7U02w
— Renal & Urology News (@renalandurology) Nov 16, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1725231517129994591Younger adults aged 18-39 years with subclinical reductions in #kidney function below their age-expected estimated glomerular filtration rate (eGFR) are at increased risk for major adverse cardiovascular events (MACE), investigators reported at #KidneyWk. https://bit.ly/3G3sC5P
— Renal & Urology News (@renalandurology) Nov 16, 2023
@poetricus2
http://twitter.com/poetricus2
https://twitter.com/poetricus2/status/1725148177458724867Para aquellos que asistieron a #kidneywk este año, mostramos exactamente lo mismo en pacientes con enfermedad renal crónica, es decir, cada infección hacía que uno tuviera más probabilidades de contraer otra, incluso si estaba vacunado. Me alegro de que no estuviéramos alucinando https://bit.ly/46xt9rP
— antonio gonzalez (@poetricus2) Nov 16, 2023
Wednesday, November 15, 2023
@diariomedico
http://twitter.com/diariomedico
https://twitter.com/diariomedico/status/1725043537186636127#KidneyWk | ➡ Modificar la #microbiota intestinal con antibióticos puede mejorar el daño renal hipertensivo. https://bit.ly/464u8zd
— Diario Médico (@diariomedico) Nov 16, 2023
@ChristosArgyrop
http://twitter.com/ChristosArgyrop
https://twitter.com/ChristosArgyrop/status/1724993884940337630For those who attended #kidneywk this year, we showed the exact same thing in patients with Chronic Kidney Disease, i.e., each infection made one more likely to get another , even if one was vaccinated. I'm glad we were not hallucinating. Poster (this is me under the N95) https://bit.ly/49BJf6k https://bit.ly/49vxgXQ
— ChristosArgyropoulos MD, PhD FlozinatorInChief (@ChristosArgyrop) Nov 16, 2023
@jordy_bc
http://twitter.com/jordy_bc
https://twitter.com/jordy_bc/status/1724835330925445300Call for suggestions for ASN #KidneyWk 2024! Please submit suggestions for HTN & Cardiorenal topics you want to hear about and speakers you want to hear from at the link 👇! Excited to work with the amazing @annetkiraboc1 on HTN content this year! https://bit.ly/3QxyR6U
— Jordy Cohen, MD, MSCE (@jordy_bc) Nov 15, 2023
@severencemacla1
http://twitter.com/severencemacla1
https://twitter.com/severencemacla1/status/1724833652943544551Has such a good time with @qasimbuttmd at @ASNKidney #kidneywk discussing how @deloreanai 's #renal #ai product is disrupting the #kidney and #dialysis market through our partnership with Innovative Renal Care!! A better way to better care!! https://bit.ly/3FYfbnM
— severence maclaughlin (@severencemacla1) Nov 15, 2023
@NephJC
http://twitter.com/NephJC
https://twitter.com/NephJC/status/1724828355118162341Curious what’s next- on Nov 28& 29? If you read our newsletter you know for sure what plans we have after #Kidneywk! If still do not know what’s next on the list, let's say will DOUBLE (hint-wink) the fun and knowledge.. #NephJC
— Nephrology Journal Club (@NephJC) Nov 15, 2023
@NephJC
http://twitter.com/NephJC
https://twitter.com/NephJC/status/1724827348296519745Well, we know it’s not as good as live recording, but look at how @hswapnil was for simultaneous podcast publishing. We know there were more happy people about, but all happened that fast and couldn’t take pics with all of them #Kidneywk #NephJC https://bit.ly/3FZ4KAf
— Nephrology Journal Club (@NephJC) Nov 15, 2023
@avalere
http://twitter.com/avalere
https://twitter.com/avalere/status/1724800793432510825Last week, #AvalereExperts attended @ASNKidney's #KidneyWk and presented on potential disparities between dual eligibles and non-dual eligibles' home #dialysis use. Read the findings here: https://bit.ly/3G24v7Q #Medicare #kidneyhealth #kidneydisease https://bit.ly/47h7RQm
— Avalere (@avalere) Nov 15, 2023
@VelezNephHepato
http://twitter.com/VelezNephHepato
https://twitter.com/VelezNephHepato/status/1724800370885661147When URINE a mood for a good day at work, ready to debate POLARIZED opinions. Showing off a generous gift from @jrseltzer during #KidneyWk #UrinarySediment #crystalluria 🔬 https://bit.ly/3QBhAtD
— Juan Carlos Q Velez (@VelezNephHepato) Nov 15, 2023
Tuesday, November 14, 2023
@NephJC
http://twitter.com/NephJC
https://twitter.com/NephJC/status/1724624763556089990Curious what’s next- on Nov 28 & 29? If you read our newsletter you know for sure what plans we have after #Kidneywk! If still do not know what’s next on the list, let's say will DOUBLE (hint-wink) the fun and knowledge.. #NephJC
— Nephrology Journal Club (@NephJC) Nov 15, 2023
@NephJC
http://twitter.com/NephJC
https://twitter.com/NephJC/status/1724623505776574589If you didn’t have time until now go listen to our podcast, which was on air perfectly synced with trial’s results, during late breaking clinical trials #KidneyWk https://bit.ly/47uXYOw https://bit.ly/3FZZ5df
— Nephrology Journal Club (@NephJC) Nov 15, 2023
@anuja_java
http://twitter.com/anuja_java
https://twitter.com/anuja_java/status/1724616536881586232@NephroSeeker @NephJC @WUNephrology Hi Cristina🥰. Been loving your #Kidneywk posts. It was wonderful to see you at the workshop.
— Anuja Java, MD (she/her) (@anuja_java) Nov 15, 2023
@NephroSeeker
http://twitter.com/NephroSeeker
https://twitter.com/NephroSeeker/status/1724608457498571259Cristina Popa, here! 👋 Just a general nephrologist wanting to learn more about kidney transplant! Here or pod 1 #NSMC 🔥 Trying to adapt my schedule back to my timezone after #Kidneywk, but when #NephJC cannot sleep anyway Pic from the park across my hospital 2 days ago 🎨✍️ https://bit.ly/3FVzySJ
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 15, 2023
@jmteakell
http://twitter.com/jmteakell
https://twitter.com/jmteakell/status/1724608271292440937Hello 👋 Jade Teakell here from @UTKidney in Houston. Excited to hear about ways we can improve the #KidneyTransplant ⚙️ process! Still thinking about these sparkly donuts from #KidneyWk… #NephJC No COI, and I’m not a transplant nephrologist fwiw https://bit.ly/3sq5yeB
— Jade Teakell (@jmteakell) Nov 15, 2023
@NephroSeeker
http://twitter.com/NephroSeeker
https://twitter.com/NephroSeeker/status/1724526990915407907I hope to see as many of you as you were in #Kidneywk LBCT session tonight or tomorrow. The LBCT session was a rush, this is the afterparty where we can discuss more about waiting list donation and kidney transplant ⏰ Chat 1 at 9pm EST #NephJC https://bit.ly/3MJuncp
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 14, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1724513134541447607Patients with ANCA-associated vasculitis renal involvement have increased plasma and urine levels of many proinflammatory cytokines, investigators reported at #KidneyWk. https://bit.ly/3QA6u8d
— Renal & Urology News (@renalandurology) Nov 14, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1724463959619613030Patients with ANCA-associated vasculitis present with advanced #kidneydiseases, with differences between 2 major histologic subtypes of the rare condition, according to an analysis of real-world data presented at #KidneyWk. https://bit.ly/3G06tWk
— Renal & Urology News (@renalandurology) Nov 14, 2023
@EthosBioscience
http://twitter.com/EthosBioscience
https://twitter.com/EthosBioscience/status/1724428218449744084If you missed us at @ASNKidney Week, see what’s new at Ethos! ConfirmCKD™ (Human kGuca2b) ELISA [RUO] is a sandwich enzyme #immunoassay for the quantitative measurement of hkGUCA2b in serum samples. https://bit.ly/3QBQwdI #worlddiabetesday #ckd #nephrology #elisa #kidneywk
— Ethos Biosciences - an Ott Scientific Company (@EthosBioscience) Nov 14, 2023
@heyscience_ai
http://twitter.com/heyscience_ai
https://twitter.com/heyscience_ai/status/1724365881277296717@msc271 @jrseltzer @JasonProsek @AyoubIsabelle What an intriguing clinical case! Presentations like this that illuminate the nuances of diagnostic reasoning are so educational. We appreciate you and @jrseltzer generously sharing insights from #KidneyWk to advance medical knowledge. Looking forward to more fascinating cases!
— HeyScience (@heyscience_ai) Nov 14, 2023
Monday, November 13, 2023
@kidneyrebel
http://twitter.com/kidneyrebel
https://twitter.com/kidneyrebel/status/1724285549811278214🙏 to the @ASNKidney, @MelissaW_ASN, and the family of Cele Fogarty for enabling people living with or caring for someone with kidney disease to attend #KidneyWk. I hope Cele's Champions develops a generation of kidney advocates who help create a world without kidney disease.
— Kidney Rebel (@kidneyrebel) Nov 14, 2023
@ChristosArgyrop
http://twitter.com/ChristosArgyrop
https://twitter.com/ChristosArgyrop/status/1724225268217262371@jfnephlolz Glad you are sticking around even after #kidneywk
— ChristosArgyropoulos MD, PhD FlozinatorInChief (@ChristosArgyrop) Nov 14, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1724107862857691281Hyperuricemia increases the risk of developing chronic #kidneydiseases (CKD), whether or not an individual is genetically predisposed to it, investigators reported at #KidneyWk. https://bit.ly/3sBUbjy
— Renal & Urology News (@renalandurology) Nov 13, 2023
@ASNKidney
http://twitter.com/ASNKidney
https://twitter.com/ASNKidney/status/1724095000793813220Janany Sabescumar, MD, an attending assistant professor at the University of Rochester, participated in her first #KidneyWk this year. She had a great experience connecting with old fellows, faculty members, and others from the industry. https://bit.ly/46bkjQi
— American Society of Nephrology (@ASNKidney) Nov 13, 2023
@KeepinItRenal1
http://twitter.com/KeepinItRenal1
https://twitter.com/KeepinItRenal1/status/1724072612937015461#thinkgenetic #NephTwitter #KidneyWk https://bit.ly/3QWeTnK
— Julianne Brown, MPH (@KeepinItRenal1) Nov 13, 2023
@collazor1
http://twitter.com/collazor1
https://twitter.com/collazor1/status/172406806889515018719 weekend nephrology consults for the call after #kidneywk Great meeting,great science followed by a weekend plenty of clinical nephrology.😂😂The best of the two worlds.👌
— Dr.Roberto Collazo-Maldonado (@collazor1) Nov 13, 2023
@arvindcanchi
http://twitter.com/arvindcanchi
https://twitter.com/arvindcanchi/status/1724047967135715639Interesting Poster that I saw on PreDiabetes (PDM) and #ckd incidence (at #KidneyWk) Persons with PDM (N=256,829) were 55% women and 56±15 years old. After a median follow-up of 2.6 years, CKD was identified in 7%. Of these, 43% had an eGFR <60 mL/min/1.73 m2. Standardized… https://bit.ly/3udotJZ https://bit.ly/471Ipy1
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 13, 2023
@arvindcanchi
http://twitter.com/arvindcanchi
https://twitter.com/arvindcanchi/status/1724030904430182769Yes, Christos makes a good point on masking. Met him at #KidneyWk recently where he was masked. I wear the n95 in hospitals and ICUs still, may need to extend it to other places perhaps 🤔 https://bit.ly/3QVjYg5 https://bit.ly/3FUJknQ
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 13, 2023
Sunday, November 12, 2023
@annetkiraboc1
http://twitter.com/annetkiraboc1
https://twitter.com/annetkiraboc1/status/1723830702150438987@Dan_Batlle @FZMarques I missed you at #kidneywk @Dan_Batlle! It came to my attention that you were in attendance.
— Annet Kirabo D.V.M., M.Sc., Ph.D., F.A.H.A. (@annetkiraboc1) Nov 12, 2023
Saturday, November 11, 2023
@KidneyWars
http://twitter.com/KidneyWars
https://twitter.com/KidneyWars/status/1723553812709802453@kidneyrebel It was amazing to meet you! #KidneyWk is pure magic, even though it feels I missed EVERYTHING!
— NoWars (@KidneyWars) Nov 12, 2023
@kidneyrebel
http://twitter.com/kidneyrebel
https://twitter.com/kidneyrebel/status/1723538665194893718My first #KidneyWk was amazing. Met so many wonderful people, went to so many great sessions, and attended awesome social events. And probably only made to a third of what I wanted to. Next year’s Kidney Week can’t arrive soon enough.
— Kidney Rebel (@kidneyrebel) Nov 12, 2023
@nephondemand
http://twitter.com/nephondemand
https://twitter.com/nephondemand/status/1723469278014267535@gunnar_heine Indeed. This one trial doesn't knock SGLT2i in my mind. As a physician community, however, we need to know the limits of this class of agents. I'm glad we are uncovering those limits sooner rather than later. #AHA23 Enjoy Philly. We were there last week for #KidneyWk.
— Tejas Desai, MD MBA (@nephondemand) Nov 11, 2023
@nephondemand
http://twitter.com/nephondemand
https://twitter.com/nephondemand/status/1723466536394834106I note that #AHA23 followed #KidneyWk 2023 in Philly. The latter was a 4-day meeting with the bulk of ed material on R,F, and S. The former is a 4-day meeting with the bulk of ed material on F,S, and U. Should #KidneyWk present more ed material on U and attract more attendees? https://bit.ly/46gco3T
— Tejas Desai, MD MBA (@nephondemand) Nov 11, 2023
@IcahnMountSinai
http://twitter.com/IcahnMountSinai
https://twitter.com/IcahnMountSinai/status/1723435700450689290Congratulations to the @ISMMSKidney Fellows on being the winners of the @ASNKidney FIT Bowl 2023 at #KidneyWk, they all worked hard to showcase their knowledge of nephrology. #Nephrology https://bit.ly/3FSKU9U
— Icahn School of Medicine at Mount Sinai (@IcahnMountSinai) Nov 11, 2023
@GrahamAbra
http://twitter.com/GrahamAbra
https://twitter.com/GrahamAbra/status/1723387869048488269The question that was often asked and indeed, was asked by @wilkiemart during the #KidneyWk oral abstract session is why included death in the SDR in addition to transfer to HD I don’t believe in therapeutic nihilism and deaths can be a signal of poor care processes
— Graham Abra, MD (@GrahamAbra) Nov 11, 2023
@Teknofiliac
http://twitter.com/Teknofiliac
https://twitter.com/Teknofiliac/status/1723366782575010111@eric_weinhandl takes the stage for an oral presentation, moderated by @GrahamAbra and @nupur_nephron, to reveal a new metric: 💥The Standardized Discontinuation Ratio 💥 This is a novel measure for real-time monitoring of #HomeDialysis discontinuation. 🧵 #ASN #KidneyWk https://bit.ly/46c0Q1V
— Wael Hussein (@Teknofiliac) Nov 11, 2023
Friday, November 10, 2023
@NephroSeeker
http://twitter.com/NephroSeeker
https://twitter.com/NephroSeeker/status/17231197301169193523/ If you don't know what PIEZOs are, don't worry, neither did many of us, until 1 wk ago! You'd probably ❤️ hypothesis: our kidneys use same molecule to sense pressure as your fingertips do to sense touch! The amazing #kidneywk plenary lecture @ardemp https://bit.ly/3QTalOQ
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 10, 2023
@NephroSeeker
http://twitter.com/NephroSeeker
https://twitter.com/NephroSeeker/status/17231197277262111562/ Maybe an undercover nephrologist, or maybe empathizing with nephrology cause, because he understands it so well, @ardemp explained to Parta Hatamizadeh how "heart is a big muscle" and it does not have PIEZO channels (pls correct me if wrongly understood😃) #KidneyWk https://bit.ly/49q3HHj
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 10, 2023
@NephroSeeker
http://twitter.com/NephroSeeker
https://twitter.com/NephroSeeker/status/1723119725033517406Sadly, there is not any special section in the CV for once-in-a-lifetime thing like this. But the heart knows better in these cases. A selfie with a @ardemp fab Nobel laureate who really gets the nephrologists, and probably the single one who will ever DM me on Twitter #KidneyWk https://bit.ly/3uaNUMm
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 10, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1723056434840060316Adults with higher urinary molybdenum levels are less likely to be diagnosed with hyperuricemia and gout, investigators reported at #KidneyWk. https://bit.ly/468DFW7
— Renal & Urology News (@renalandurology) Nov 10, 2023
@SarahSanghavi
http://twitter.com/SarahSanghavi
https://twitter.com/SarahSanghavi/status/1723014305103397235Interesting article showing that CF carrier status is associated with a higher risk of volume depletion and hypokalemia compared with controls. Reminds me of a case presented at #KidneyWk from @Rush_Nephrology. https://bit.ly/4685IoC
— Sarah Sanghavi (@SarahSanghavi) Nov 10, 2023
@TravereRare
http://twitter.com/TravereRare
https://twitter.com/TravereRare/status/1723010913349906511Thank you to everyone who joined us at @ASNKidney #ASN23 #KidneyWk and who share our commitment to bringing innovation to people living with #IgAN and #FSGS. We are grateful to all those who contributed to another thought-provoking meeting on advances in #RareKidneyDisease (RKD). https://bit.ly/3QyBR31
— Travere Therapeutics (@TravereRare) Nov 10, 2023
@pittkidneyctr
http://twitter.com/pittkidneyctr
https://twitter.com/pittkidneyctr/status/1722986030192624048Love seeing our team together for @ASNKidney #KidneyWk ! https://bit.ly/3SD6Tt0
— Univ of Pitt Center for Kidney Research (@pittkidneyctr) Nov 10, 2023
@dra_miliflores
http://twitter.com/dra_miliflores
https://twitter.com/dra_miliflores/status/1722977420360487163Novedades #enfermedadrenal #sparsentan vs #irbesartan ⛔️Sin #RAAS ⬇️Remisión proteinuria ✅ ➡️Retraso en la necesidad TSR DUPLEX phase 3 trial 👏@rheault_m @NEJM #KidneyWk #nefroneando #ISNyoung #ThisIsISN https://bit.ly/49x0t4Q https://bit.ly/3ss04zQ
— Milagros Flores (@dra_miliflores) Nov 10, 2023
@PamelaVasquez88
http://twitter.com/PamelaVasquez88
https://twitter.com/PamelaVasquez88/status/1722962609056399680More #KidneyWk memories! @PalNeph_NM @NephCrit_NM @Nephr0s @ChristosArgyrop @captainchloride Opeyemi Olabisi https://bit.ly/4773ffs
— Pamela Vasquez (@PamelaVasquez88) Nov 10, 2023
@PamelaVasquez88
http://twitter.com/PamelaVasquez88
https://twitter.com/PamelaVasquez88/status/1722955759548338399More #KidneyWk memories! https://bit.ly/3FTO5yc
— Pamela Vasquez (@PamelaVasquez88) Nov 10, 2023
Thursday, November 9, 2023
@azzilab
http://twitter.com/azzilab
https://twitter.com/azzilab/status/1722734649590325541🌟 Reflecting on an inspiring week @ASNKidney #kidneywk 2023! 🌟 We witnessed the incredible work of our own #womeninnephrology. Very grateful to ASN for the invitation to present our work. https://bit.ly/3SztQxm
— J.Azzilab (@azzilab) Nov 9, 2023
@WUNephrology
http://twitter.com/WUNephrology
https://twitter.com/WUNephrology/status/1722640983601369500Sharing old memories and making new ones, current and former members of the division, with family and friends, attended @WUNephrology's Alumni and Friends Reception at @ASNKidney #KidneyWk 2023. See slideshow in link. https://bit.ly/40t2F9n
— WU in STL Nephrology (@WUNephrology) Nov 9, 2023
@GESGlobal
http://twitter.com/GESGlobal
https://twitter.com/GESGlobal/status/1722630121276731703From across the globe, 12,000+ kidney professionals gathered for @ASNKidney Kidney Week 2023 held at the @PAConvention! 🌍💼✨ @GES_EMEA I @GESMiddleEast I @GES_Canada #KidneyWk #visitphilly #conventioncenters #exhibitions #tradeshows #growtogether https://bit.ly/3svaz5t https://bit.ly/3SzCkEx
— GES (@GESGlobal) Nov 9, 2023
@LoriBaker444
http://twitter.com/LoriBaker444
https://twitter.com/LoriBaker444/status/1722608847049859222Still catching up on the plethora of data presented at #KidneyWk for #IgAN and Glomerular Diseases as a whole. The poster rows were packed Saturday! Had to fight the crowd to get a minute w/ @BradRovin! https://bit.ly/3FQB8VJ
— Lori Baker (@LoriBaker444) Nov 9, 2023
@HCPLiveNews
http://twitter.com/HCPLiveNews
https://twitter.com/HCPLiveNews/status/1722599924460568704ICYMI: As part of our #KidneyWk coverage, we are spotlighting a select group of abstracts from the meeting highlighting racial disparities in the world of #nephrology Learn more: https://bit.ly/47pmRv3
— HCPLive (@HCPLiveNews) Nov 9, 2023
@ASPNeph
http://twitter.com/ASPNeph
https://twitter.com/ASPNeph/status/1722584901151572121Patient navigator intervention seen as safe, useful for children newly diagnosed with #CKD https://bit.ly/3Qvg38q @GoHealio presented at #KidneyWk
— American Society of Pediatric Nephrology (@ASPNeph) Nov 9, 2023
Wednesday, November 8, 2023
@arvindcanchi
http://twitter.com/arvindcanchi
https://twitter.com/arvindcanchi/status/1722444116057797040Met with @kidney_boy on the last day of #KidneyWk. Thanks to @NephroSeeker for the pic! Also note @brian_rifkin in the picture. https://bit.ly/47hJkKE
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 9, 2023
@JWatch
http://twitter.com/JWatch
https://twitter.com/JWatch/status/1722409297068556528In NEJM Group's final report on #KidneyWk, our clinician-guides, @MegSise and @OpeyemiOlabisi8, share key takeaways from the nephrology meeting and how these findings might change their practice. https://bit.ly/3Qu02Q8 https://bit.ly/40tQ99o
— NEJM Journal Watch (@JWatch) Nov 9, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1722302970010747251Zibotentan, a selective endothelin A receptor antagonist, may further reduce albuminuria in patients with chronic #kidneydiseases (CKD) when added to SGLT2 inhibitor therapy, investigators reported at #KidneyWk. https://bit.ly/49stfTV
— Renal & Urology News (@renalandurology) Nov 8, 2023
@CarelonResearch
http://twitter.com/CarelonResearch
https://twitter.com/CarelonResearch/status/1722297937030762877In collaboration with @boehringerus, we conducted the first large-scale U.S. validation of a new AI-driven tool to predict risk of chronic kidney disease progression. Learn more: https://t.co/WtScZRunWG #KidneyWk #CKD #news #PressRelease https://bit.ly/4617Uy1
— Carelon Research (@CarelonResearch) Nov 8, 2023
@UNMCkidney
http://twitter.com/UNMCkidney
https://twitter.com/UNMCkidney/status/1722297931519119762Amongst the best parts of #KidneyWk for our team was that Dr. Wekesa's parents came to Philadelphia to see her present!!! https://bit.ly/465irbt https://bit.ly/47pgKa8
— UNMC Kidney (@UNMCkidney) Nov 8, 2023
@KPMProject
http://twitter.com/KPMProject
https://twitter.com/KPMProject/status/1722284975918063753And the votes are in...the unanimous decision was that #KidneyWk 2023 was a blast! 🎉 Thank you to all who featured #KPMP data and congratulations to all presenters and award recipients! It's definitely safe to say that we are already counting down the days until next year https://bit.ly/47sAk5n
— Kidney Precision Medicine Project (@KPMProject) Nov 8, 2023
@ISGDtweets
http://twitter.com/ISGDtweets
https://twitter.com/ISGDtweets/status/1722270859992469806Our reflections on #KidneyWk and the vibrant glomerular community there: https://bit.ly/3MBunLf
— International Society of Glomerular Disease (@ISGDtweets) Nov 8, 2023
@ASPNeph
http://twitter.com/ASPNeph
https://twitter.com/ASPNeph/status/1722267884431548478Study: Chimerism seen as successful in living-related kidney donors https://bit.ly/3FT8JOZ @GoHealio presented at #KidneyWk #Transplant
— American Society of Pediatric Nephrology (@ASPNeph) Nov 8, 2023
@HCPLiveNews
http://twitter.com/HCPLiveNews
https://twitter.com/HCPLiveNews/status/1722237542446367054Catch up on anything you might have missed from #KidneyWk by heading over to our conference coverage page: https://bit.ly/49hZoh3
— HCPLive (@HCPLiveNews) Nov 8, 2023
@SannaCherchiLab
http://twitter.com/SannaCherchiLab
https://twitter.com/SannaCherchiLab/status/1722232335175930236And no better way to close our posts (delayed) from #KidneyWk with a night out with the gang! Thank you guys!! @JMartinoActual @GuptaYask @tzeyinlim #FSGS #CAKUT #beer #genetics #nephrology #pediatrics #nephroticsyndrome https://bit.ly/3SCCr2p
— SSC_Lab 🧬 (@SannaCherchiLab) Nov 8, 2023
@ATCC_LGC
http://twitter.com/ATCC_LGC
https://twitter.com/ATCC_LGC/status/1722223211361026399We hope you had a fantastic time presenting at @ASNKidney #KidneyWk, @benofreedman! Its so exciting to see #Organoids getting the spotlight at fantastic events like this 🙌 #OrganoidPower https://bit.ly/47lDXK5
— LGC in partnership with ATCC (@ATCC_LGC) Nov 8, 2023
Tuesday, November 7, 2023
@IcahnMountSinai
http://twitter.com/IcahnMountSinai
https://twitter.com/IcahnMountSinai/status/1721936388268929216Congratulations to our @ISMMSKidney fellows for presenting their work at #KidneyWk! @DureyaSyed @Doug_Rud @RahulM_MD @DOMSinaiNYC #Nephrology https://bit.ly/47mmBNf
— Icahn School of Medicine at Mount Sinai (@IcahnMountSinai) Nov 7, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1721936051977990516Oral urea effectively treats hyponatremia in patients with the syndrome of inappropriate antidiuresis (SIAD) who fail to respond to fluid restriction, investigators reported at #KidneyWk. https://bit.ly/3QPlbFu
— Renal & Urology News (@renalandurology) Nov 7, 2023
@UNMCkidney
http://twitter.com/UNMCkidney
https://twitter.com/UNMCkidney/status/1721935543410254192Dr. Wekesa of @UNMCIMResidency presented her oral abstract "Outcome of OPTN Policy Allowing for Waiting Time Modification for Candidates Affected by Race-Inclusive eGFR Calculations" during the "Top Trainee" Session at @ASNKidney #KidneyWk! https://bit.ly/3smL6Ly
— UNMC Kidney (@UNMCkidney) Nov 7, 2023
@ISMMSKidney
http://twitter.com/ISMMSKidney
https://twitter.com/ISMMSKidney/status/1721931435458654249Congratulations to our fellows! #KidneyWk #Nephrology https://bit.ly/40qaHQk
— Barbara T. Murphy Mount Sinai Div. of Nephrology (@ISMMSKidney) Nov 7, 2023
@IcahnMountSinai
http://twitter.com/IcahnMountSinai
https://twitter.com/IcahnMountSinai/status/1721925293785448681Congratulations to our @ISMMSKidney #KidneyWk Fellows-In-Training Bowl Champions! 🏆 @MadhusudanV92 @suresh_varsh94 @AbhinayaS15 @Doug_Rud @DOMSinaiNYC #Nephrology #MedEd https://bit.ly/47lK2GB
— Icahn School of Medicine at Mount Sinai (@IcahnMountSinai) Nov 7, 2023
@AstraZenecaUS
http://twitter.com/AstraZenecaUS
https://twitter.com/AstraZenecaUS/status/1721924239916253211Last week, we presented real-world evidence during @ASNKidney #KidneyWk. It's crucial to continue educating communities about the risks patients face from the connectivity of renal disease and cardiovascular events. @ASNKidney #ASN2023 https://bit.ly/468mP9M
— AstraZenecaUS (@AstraZenecaUS) Nov 7, 2023
@renalandurology
http://twitter.com/renalandurology
https://twitter.com/renalandurology/status/1721918778773045568The risks for cardiovascular and renal events do not differ between new febuxostat and allopurinol users who have stage 3 or higher chronic #kidneydiseases (CKD) not on dialysis, investigators reported at #KidneyWk. https://bit.ly/40sCuQ4
— Renal & Urology News (@renalandurology) Nov 7, 2023
@jmteakell
http://twitter.com/jmteakell
https://twitter.com/jmteakell/status/1721883562302226633Brought some coffee beans home from #KidneyWk #MedGrind @OldCityCoffee ☕️ https://bit.ly/49pGogE
— Jade Teakell (@jmteakell) Nov 7, 2023
@KidneyFund
http://twitter.com/KidneyFund
https://twitter.com/KidneyFund/status/1721882533540118565@jbbayton @ASNKidney @AKF_Advocacy Thank you so much for stopping by our booth, John! It's always a pleasure seeing and connecting with you. #KidneyWk
— American Kidney Fund (@KidneyFund) Nov 7, 2023
@ChristosArgyrop
http://twitter.com/ChristosArgyrop
https://twitter.com/ChristosArgyrop/status/1721877999711047697@kidney_boy Another way to look at this is tweet/participant -> less engagement. It would be interesting to see how many ppl actually attended #KidneyWk and thus generated primary content. Note that we are back to 2015. Twitter was dying back then & got 2 boosts afterwards ie Trump & COVID
— ChristosArgyropoulos MD, PhD FlozinatorInChief (@ChristosArgyrop) Nov 7, 2023
@Calliditas1
http://twitter.com/Calliditas1
https://twitter.com/Calliditas1/status/1721875203347611871It was an honor to connect with the rare #KidneyDisease community at @ASNKidney’s #KidneyWk & showcase our pioneering work in IgA nephropathy. Learn about the additional analyses we presented from our Ph3 NefIgArd trial for the treatment of #IgAN, & more: https://bit.ly/3QrfcW8 https://bit.ly/3Qrff4g
— Calliditas Therapeutics (@Calliditas1) Nov 7, 2023
@hswapnil
http://twitter.com/hswapnil
https://twitter.com/hswapnil/status/1721870015522062669@eric_weinhandl @GrahamAbra @StanfordNeph @TammySirich There you go! #KidneyWk post discussions https://bit.ly/3FSGKyE
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Nov 7, 2023
@hswapnil
http://twitter.com/hswapnil
https://twitter.com/hswapnil/status/1721852494085546238@kidney_boy What’s the point? These are extremely low risk patients They don’t show any benefit ( infection rates same) Possibly in older/higher risk recipients at high risk of PTLD/CVD this might matter? BTW same group had another LBCT with N = 2 in 2021 see #KidneyWk https://bit.ly/3FNZ4cp
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Nov 7, 2023
Monday, November 6, 2023
@m_furlano
http://twitter.com/m_furlano
https://twitter.com/m_furlano/status/1721544708248293848➡️Si no has podido ir al congreso americano de nefrologia #KidneyWk aquí puedes ver la sesión de los 🧪ensayos clínicos de alto impacto @SENefrologia @senjoven @nefrocat 👇🏻👇🏻👇🏻 https://bit.ly/40tHiow
— Mónica Furlano (@m_furlano) Nov 6, 2023
@gudnephron
http://twitter.com/gudnephron
https://twitter.com/gudnephron/status/1721544396074811445Not surprised by this trend. But feel bad about it. @ASNKidney #KidneyWk https://bit.ly/3snSW7z
— Prakash Gudsoorkar (@gudnephron) Nov 6, 2023
@ReliantGlyco
http://twitter.com/ReliantGlyco
https://twitter.com/ReliantGlyco/status/1721544243112513855During our week in Philly, we had significant conversations and connections with some of the greatest in the world. #KidneyWk 2023 had over 12K participants from over 100 countries, and our team had a remarkable time! Thank you, @ASNKidney, for having us. See you next year! https://bit.ly/40yjjnZ
— Reliant Glycosciences LLC (@ReliantGlyco) Nov 6, 2023
@SannaCherchiLab
http://twitter.com/SannaCherchiLab
https://twitter.com/SannaCherchiLab/status/1721526273980215320Great oral abstracts session on pediatric nephrology ! Everyone rocked , from basic to translational to clinical research. Nicely moderated by Patty Weng @UCLAPedsNeph and Namrata Jain ! #KidneyWk #CAKUT #FSGS @ASNKidney @ASPNeph @JASN_News @thePNRC @IPNA_PedNeph @Ped_Neph… https://bit.ly/49rCMuL https://bit.ly/49lOy9Q
— SSC_Lab 🧬 (@SannaCherchiLab) Nov 6, 2023
@brian_rifkin
http://twitter.com/brian_rifkin
https://twitter.com/brian_rifkin/status/1721515907917165003@LeticiaRolonMD @ethier_isabelle @womeninnephro @CSNSCN I always miss the good stuff! It was the finerenone booth wasn’t it. 😂 Seriously, there were more 👶 than I remember from previously. For those who think having women in leadership doesn’t matter, it does (ie breastfeeding areas) #BringTheKids #KidneyWk @womeninnephro
— Brian Rifkin, MD (@brian_rifkin) Nov 6, 2023
@santy431
http://twitter.com/santy431
https://twitter.com/santy431/status/1721495305009398068PROTECT junto con DUPLEX y ZENITH. Fue su semana! #KidneyWk https://bit.ly/3QLKoRm
— Santiago Moreno T. (@santy431) Nov 6, 2023
@pharmaphorum
http://twitter.com/pharmaphorum
https://twitter.com/pharmaphorum/status/1721493907165298994SGLT2-based combination therapies from @AstraZeneca and @Boehringer raise the prospect of improved therapy for chronic #kidneydisease. #KidneyWk https://bit.ly/3QJJbKo https://bit.ly/3QujfkJ
— pharmaphorum (@pharmaphorum) Nov 6, 2023
@PakAmericanh
http://twitter.com/PakAmericanh
https://twitter.com/PakAmericanh/status/1721490047302779216Stem Cells when introduced into the body, these specialized cells can differentiate into kidney-specific cell types, aiding in the repair and regeneration of damaged renal tissues. #Health #kidneyweek #KidneyDisease #KidneyWk #healthcare https://bit.ly/46Zg2AB
— Pak American Hospital (@PakAmericanh) Nov 6, 2023
@hswapnil
http://twitter.com/hswapnil
https://twitter.com/hswapnil/status/1721486731940155565@HecmagsMD Indeed - my colleague David Massicotte also said the same for how French works Hmmm - so maybe our reenin/wrennin fight is also misguided 😳🤔 #kidneyWk
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Nov 6, 2023
@SannaCherchiLab
http://twitter.com/SannaCherchiLab
https://twitter.com/SannaCherchiLab/status/1721464615307985370Great session with ample breadth, and very well moderated. Just a very pleasant way to conclude an outstanding #KidneyWk talking about #Alport #CAKUT #APOL1 #FSGS #nephroticsyndrome #genetics and more! @ASNKidney @JASN_News @CureGn @ASPNeph @nephcure @NephroticF @thePNRC https://bit.ly/3QMF5Bi
— SSC_Lab 🧬 (@SannaCherchiLab) Nov 6, 2023
@SaadTheodore
http://twitter.com/SaadTheodore
https://twitter.com/SaadTheodore/status/1721450369383846037@bernardo_moguel @wasse_m @EmoryNephrology @vandyniyyar @JasonCobbMD @ASDINNews Visiting the posters with so many bright young investigators was a high point of #KidneyWk Beautiful to see the incomparable @wasse_m engage each presenter with genuine, enthusiastic interest, “Tell me about your poster!” I know this left an indelible mark on each of them https://bit.ly/3MvDD3M
— Theodore Saad (@SaadTheodore) Nov 6, 2023
Sunday, November 5, 2023
@TheBeaniac
http://twitter.com/TheBeaniac
https://twitter.com/TheBeaniac/status/1721125309951451514Canadian Onco-Neph representation at ASN #KidneyWk 2023. @onconeph @NabilAbuAmer1 @NephroGuy @KevinYauMD, Vikas Shridhar, Louis Pinard, Marko Skrtic, Anukul Ghimire https://bit.ly/45ZlTEO
— Avinash Rao Ullur, MD DNB FASN AHSCP-CHS (@TheBeaniac) Nov 5, 2023
@kristintp
http://twitter.com/kristintp
https://twitter.com/kristintp/status/1721094665028423882@ollie_fox1 first #KidneyWk… budding nephrologist in the making 😉 @CIRUsoton @UHSFTresearch @UHSFT https://bit.ly/49qfIwu
— Kristin Veighey (@kristintp) Nov 5, 2023
@livingdialysis
http://twitter.com/livingdialysis
https://twitter.com/livingdialysis/status/1721066225143582899ASN kidney week #kidneywk #asn #dialysis https://bit.ly/460RjdC
— BLIND CHICK LIVING on dialysis (@livingdialysis) Nov 5, 2023
@TetsuroKusaba
http://twitter.com/TetsuroKusaba
https://twitter.com/TetsuroKusaba/status/1721053084984410207Our poster on renal congestion and sepsis-AKI was selected as star poster. See the mark right bottom!! #KidneyWk #itarunakamura https://bit.ly/47kXOcm
— Tetsuro Kusaba (@TetsuroKusaba) Nov 5, 2023
@TetsuroKusaba
http://twitter.com/TetsuroKusaba
https://twitter.com/TetsuroKusaba/status/1721050185017504207Good discussion. Our clinical research on first quantitative taste test for high salt aversion. #KidneyWk #natsukookuno https://bit.ly/3FLi9vP
— Tetsuro Kusaba (@TetsuroKusaba) Nov 5, 2023
@smirioglu
http://twitter.com/smirioglu
https://twitter.com/smirioglu/status/1721047666044362800☀️ Perfect weather for a Sunday morning ride! #cycling 🚴🏻♂️ Would prefer to be at #KidneyWk though. Maybe next year! 🤞🏻 https://bit.ly/3tSLT7d
— Safak Mirioglu (@smirioglu) Nov 5, 2023
@jcaldwelldo
http://twitter.com/jcaldwelldo
https://twitter.com/jcaldwelldo/status/1721047567474274511More highlights from @ASNKidney #KidneyWk in Philly - pizza, cheesesteak and karaoke with the @StanfordNeph crew https://bit.ly/3MtmWWu
— Jillian Caldwell (@jcaldwelldo) Nov 5, 2023
@Negiin08957393
http://twitter.com/Negiin08957393
https://twitter.com/Negiin08957393/status/1721044735966556202Outstanding presence by our fellows at #KidneyWk 2023. We are proud of you! @MedStarGUHNeph @KeikoGNeph https://bit.ly/3tYDiQt
— Negiin Pourafshar, MD, FASN (@Negiin08957393) Nov 5, 2023
Saturday, November 4, 2023
@NIPOKA_Podocyte
http://twitter.com/NIPOKA_Podocyte
https://twitter.com/NIPOKA_Podocyte/status/1720763398839783793SA-PO1023: Together with INSERM, our study shows changes in the #podocyte foot process structure preceding proteinuria. @ASNKidney #KidneyWk https://bit.ly/45YPfmw
— NIPOKA (@NIPOKA_Podocyte) Nov 4, 2023
@rheault_m
http://twitter.com/rheault_m
https://twitter.com/rheault_m/status/1720761762927046797So yes, I finally got that mammogram and 4 weeks ago found that I have breast cancer. I have cancer. Still hard to say. Find myself tearing up for no good reason. Now I’m the one being approached for consent for a clinical trial instead of the one running it. #KidneyWk
— Michelle Rheault (@rheault_m) Nov 4, 2023
@rheault_m
http://twitter.com/rheault_m
https://twitter.com/rheault_m/status/1720761760389448181I had other people to take care of. My family, my colleagues. I never made taking care of me a priority. Hell, I have hundreds of dollars in unused gift cards to a spa that I got 9 months ago but have been “too busy” to use. #KidneyWk
— Michelle Rheault (@rheault_m) Nov 4, 2023
@rheault_m
http://twitter.com/rheault_m
https://twitter.com/rheault_m/status/1720761757981921359See, I was always too “busy”. That’s kind of my thing. As a first generation physician, I’ve always felt like I’ve had to hustle to get ahead. Do more. Write more. Be more. There was never time. #KidneyWk
— Michelle Rheault (@rheault_m) Nov 4, 2023
@rheault_m
http://twitter.com/rheault_m
https://twitter.com/rheault_m/status/1720761754802594132Yesterday was a really good day. Maybe even a career high. I should be popping the 🍾. But with every high has to come a low, right? That’s how this works. Have you been getting your mammograms like you’re supposed to? I haven’t. 🧵 #KidneyWk #WomenInMedicine
— Michelle Rheault (@rheault_m) Nov 4, 2023
@MiamiNephrology
http://twitter.com/MiamiNephrology
https://twitter.com/MiamiNephrology/status/1720761558102392846Not to brag but we might have the best fellows at #KidneyWk! The nephron squad https://bit.ly/40lPkj3
— University of Miami Nephrology (@MiamiNephrology) Nov 4, 2023
@KidneyNews
http://twitter.com/KidneyNews
https://twitter.com/KidneyNews/status/1720757789264384493In today's plenary, expert to share current efforts to combat emerging diseases https://bit.ly/3MsUNyX #KidneyWk @EOSaphire @kdjhaveri @ASNKidney https://bit.ly/45ZBVhJ
— ASN Kidney News (@KidneyNews) Nov 4, 2023
@Cystatin_C
http://twitter.com/Cystatin_C
https://twitter.com/Cystatin_C/status/1720750086102163809We have had a great time here at #kidneyWK discussing #cystatinC's role in #ChronicKidneyDiseas. Today is the last day, make sure to visit us at booth #2016 https://bit.ly/3FJKse1
— Cystatin C (@Cystatin_C) Nov 4, 2023
@AJKDonline
http://twitter.com/AJKDonline
https://twitter.com/AJKDonline/status/1720742999548711225#KidneyWk CALL FOR SUBMISSIONS: Have you encountered a tricky case that could be submitted as a Quiz to help others learn? Details on the #AJKDBlog: https://bit.ly/3FIwTM3 All Quizzes are freely available: https://bit.ly/3tUcd0K https://bit.ly/47ggh9X
— AJKD (@AJKDonline) Nov 4, 2023
@NephRodby
http://twitter.com/NephRodby
https://twitter.com/NephRodby/status/1720735120968052943@kkalra_22 @NephroMD @amyaimei @PITTRenal @ASNKidney “Calming the Waters” turned into a tsunami during the Q&A as the discussion got heated in reference to https://bit.ly/46fkUk1 . #KidneyWk https://bit.ly/464np8u
— Roger Rodby (@NephRodby) Nov 4, 2023
Subscribe to:
Posts (Atom)